非小细胞肺癌患者组织中lncRNA MAGI2-AS3的表达及与病理参数和预后的关系  

Expression of lncRNA MAGI2-AS3 in tissues of patients with non-small cell lung cancer and the relationship with pathological parameters and prognosis

作　　者：杨广惠 潘慧敏[2] 查丽芬 顾俊 YANG Guanghui;PAN Huimin;ZHA Lifen;GU Jun(Medical School of Nantong University,Jiangsu Province,Nantong 226001,China;Department of Respiratory Medicine,Danyang People’s Hospital Affiliated to Nantong University,Jiangsu Province,Danyang 212300,China)

机构地区：[1]南通大学医学院,江苏南通226001 [2]南通大学附属丹阳市人民医院呼吸内科,江苏丹阳212300

出　　处：《中国医药导报》2022年第20期104-107,共4页China Medical Herald

基　　金：江苏省卫生健康委医学科研项目(JH19012)。

摘　　要：目的探讨非小细胞肺癌(NSCLC)患者组织中长链非编码RNA(lncRNA)膜相关鸟苷酸激酶包含WW和PDZ结构域2-反义RNA 3(MAGI2-AS3)的表达及与病理参数和预后的关系。方法选取2016年8月至2018年8月南通大学附属丹阳市人民医院收治的103例NSCLC患者,检测癌组织与癌旁组织中lncRNA MAGI2-AS3表达,分析lncRNA MAGI2-AS3表达与NSCLC患者病理参数的关系。根据lncRNA MAGI2-AS3表达水平将患者分为高lncRNA MAGI2-AS3表达组(≥lncRNA MAGI2-AS3表达均值)和低lncRNA MAGI2-AS3表达组(<lncRNA MAGI2-AS3表达均值)。Kaplan-Meier法绘制NSCLC患者术后3年生存曲线,多因素Cox回归分析NSCLC患者预后影响因素。结果NSCLC组织中lncRNA MAGI2-AS3表达低于癌旁组织,差异有统计学意义(P<0.05)。不同TNM分期、淋巴结转移患者lncRNA MAGI2-AS3表达比较,差异有统计学意义(P<0.05)。高lncRNA MAGI2-AS3表达组(51例)中位生存时间长于低lncRNA MAGI2-AS3表达组(52例),差异有统计学意义(P<0.05)。多因素Cox回归分析显示,肿瘤分化程度、TNM分期、淋巴结转移情况、lncRNA MAGI2-AS3表达水平是NSCLC患者预后不良的影响因素(P<0.05)。结论NSCLC组织中lncRNA MAGI2-AS3低表达,与TNM分期、淋巴结转移、预后不良有关,可作为NSCLC患者预后评估指标。Objective To investigate the expression of long non-coding RNA(lncRNA)membrane associated guanylate kinase,WW,and PDZ domain containing two-antisense RNA three(MAGI2-AS3)in non-small cell lung cancer(NSCLC)patient tissues and the relationship with pathological parameters and prognosis.Methods One hundred and three patients with NSCLC admitted to Danyang People’s Hospital Affiliated to Nantong University from August 2016 to August 2018 were selected.The expressions of lncRNA MAGI2-AS3 in cancer tissues and adjacent tissues were detected.The relationship between lncRNA MAGI2-AS3 expression and pathological parameters of NSCLC patients was analyzed.According to lncRNA MAGI2-AS3 expression level,patients were divided into high lncRNA MAGI2-AS3 expression group(≥mean lncRNA MAGI2-AS3 expression level)and low lncRNA MAGI2-AS3 expression group(<mean lncRNA MAGI2-AS3 expression level).The three-year survival curve of NSCLC patients was drawn by using Kaplan-Meier method.Prognostic factors of NSCLC patients were analyzed by using multi-factor Cox regression.Results The expression of lncRNA MAGI2-AS3 in NSCLC tissues was lower than that in adjacent tissues,the difference was statistically significant(P<0.05).There were significant differences in the expression of lncRNA MAGI2-AS3 in patients with different TNM stages and lymph node metastasis(P<0.05).The median survival time of high lncRNA MAGI2-AS3 expression group(51 cases)was longer than that of low lncRNA MAGI2-AS3 expression group(52 cases),the difference was statistically significant(P<0.05).Multivariate Cox regression analysis showed that degree of tumor differentiation,TNM stage,lymph node metastasis,and expression level of lncRNA MAGI2-AS3 were influencing factors for poor prognosis in patients with NSCLC(P<0.05).Conclusion The low expression of lncRNA MAGI2-AS3 in NSCLC tissues is related to TNM stage,lymph node metastasis,and poor prognosis,which can be used as a prognostic indicator for NSCLC patients.

关 键 词：非小细胞肺癌 长链非编码RNA 膜相关鸟苷酸激酶包含WW和PDZ结构域-2反义RNA3 预后 

分 类 号：R734.2[医药卫生—肿瘤]